I'm kind of thinking the pick for the Dept of Education may in fact be an idiot. Probably not the best pick. But the problem the left is running into, repeatedly, is that by trying to destroy every pick, no matter how good they may be, with flimsy, stupid "evidence" such as this against Price, Session, etc, makes the common folk just roll their eyes when there is actually someone or something they ought to really be pissed about. Keep up the great work CNN, et. al. You are doing your part to make sure it's not just 4 years, it'll be 8.
JANUARY 18, 2017 PUNCHING BACK TWICE AS HARD: So I just got this letter from Trump’s transition team: On January 16, 2017, CNN broadcast a story by Manu Raju, titled “First on CNN: Trump’s Cabinet pick invested in company, then introduced a bill to help it”, which omitted facts and drew conclusions in an effort to attack President-Elect Donald Trump’s designee for Secretary of Health and Human Services, Dr. Tom Price.
The facts were available to CNN through House Financial Disclosure Filings. Dr. Price’s position on the Comprehensive Joint Replacement demonstration, which date back to fall 2015, is also a matter of public record.
The facts are:
• Dr. Tom Price has a diversified portfolio with Morgan Stanley in a broker-directed account. The portfolio includes both health care and non-health care related stocks. • Dr. Price’s Morgan Stanley financial advisor designed his portfolio and directed all trades in the account. Pursuant to the arrangement with Morgan Stanley, the financial advisor, and not Dr. Price, has the discretion to decide which securities to buy and sell in his account. • Dr. Price’s financial advisor periodically rebalances his portfolio to ensure proper diversification. On March 17, 2016, Morgan Stanley undertook a comprehensive rebalancing of Dr. Price’s portfolio. In the course of that rebalancing, the advisor purchased 26 shares of Zimmer Biomet, worth $2,697.74, on behalf of Dr. Price. • Dr. Price learned of the purchase of Zimmer Biomet on April 4, 2016, when his financial advisor sent him a list of trades to be disclosed on his House Periodic Transaction Report (PTR). • Dr. Price submitted the PTR reflecting the March trades on April 15, 2016. • Dr. Price began work on his legislative effort to delay the comprehensive joint replacement demonstration project in 2015 in order to preserve treatment options for patients. He sent a Dear Colleague letter regarding this effort on September 21, 2015.
The Presidential Transition Team requests that CNN retract this blatantly false story.
JANUARY 18, 2017 PUNCHING BACK TWICE AS HARD: So I just got this letter from Trump’s transition team: On January 16, 2017, CNN broadcast a story by Manu Raju, titled “First on CNN: Trump’s Cabinet pick invested in company, then introduced a bill to help it”, which omitted facts and drew conclusions in an effort to attack President-Elect Donald Trump’s designee for Secretary of Health and Human Services, Dr. Tom Price.
The facts were available to CNN through House Financial Disclosure Filings. Dr. Price’s position on the Comprehensive Joint Replacement demonstration, which date back to fall 2015, is also a matter of public record.
The facts are:
• Dr. Tom Price has a diversified portfolio with Morgan Stanley in a broker-directed account. The portfolio includes both health care and non-health care related stocks. • Dr. Price’s Morgan Stanley financial advisor designed his portfolio and directed all trades in the account. Pursuant to the arrangement with Morgan Stanley, the financial advisor, and not Dr. Price, has the discretion to decide which securities to buy and sell in his account. • Dr. Price’s financial advisor periodically rebalances his portfolio to ensure proper diversification. On March 17, 2016, Morgan Stanley undertook a comprehensive rebalancing of Dr. Price’s portfolio. In the course of that rebalancing, the advisor purchased 26 shares of Zimmer Biomet, worth $2,697.74, on behalf of Dr. Price. • Dr. Price learned of the purchase of Zimmer Biomet on April 4, 2016, when his financial advisor sent him a list of trades to be disclosed on his House Periodic Transaction Report (PTR). • Dr. Price submitted the PTR reflecting the March trades on April 15, 2016. • Dr. Price began work on his legislative effort to delay the comprehensive joint replacement demonstration project in 2015 in order to preserve treatment options for patients. He sent a Dear Colleague letter regarding this effort on September 21, 2015.
The Presidential Transition Team requests that CNN retract this blatantly false story.
the wall street journal came out with a story a while ago showing 2 companies he invested in that his legislation would potentially benefit. One of those companies was innate immuno.
Price admitted in the hearing today that he personally chose to purchase the stock in innate immuno.
Trump's team said that all of his trades were broker directed.
the fact that he received campaign contributions from that company after introducing that law is far worse. but that corruption is everywhere and not exclusive to price by any means
JANUARY 18, 2017 PUNCHING BACK TWICE AS HARD: So I just got this letter from Trump’s transition team: On January 16, 2017, CNN broadcast a story by Manu Raju, titled “First on CNN: Trump’s Cabinet pick invested in company, then introduced a bill to help it”, which omitted facts and drew conclusions in an effort to attack President-Elect Donald Trump’s designee for Secretary of Health and Human Services, Dr. Tom Price.
The facts were available to CNN through House Financial Disclosure Filings. Dr. Price’s position on the Comprehensive Joint Replacement demonstration, which date back to fall 2015, is also a matter of public record.
The facts are:
• Dr. Tom Price has a diversified portfolio with Morgan Stanley in a broker-directed account. The portfolio includes both health care and non-health care related stocks. • Dr. Price’s Morgan Stanley financial advisor designed his portfolio and directed all trades in the account. Pursuant to the arrangement with Morgan Stanley, the financial advisor, and not Dr. Price, has the discretion to decide which securities to buy and sell in his account. • Dr. Price’s financial advisor periodically rebalances his portfolio to ensure proper diversification. On March 17, 2016, Morgan Stanley undertook a comprehensive rebalancing of Dr. Price’s portfolio. In the course of that rebalancing, the advisor purchased 26 shares of Zimmer Biomet, worth $2,697.74, on behalf of Dr. Price. • Dr. Price learned of the purchase of Zimmer Biomet on April 4, 2016, when his financial advisor sent him a list of trades to be disclosed on his House Periodic Transaction Report (PTR). • Dr. Price submitted the PTR reflecting the March trades on April 15, 2016. • Dr. Price began work on his legislative effort to delay the comprehensive joint replacement demonstration project in 2015 in order to preserve treatment options for patients. He sent a Dear Colleague letter regarding this effort on September 21, 2015.
The Presidential Transition Team requests that CNN retract this blatantly false story.
JANUARY 18, 2017 PUNCHING BACK TWICE AS HARD: So I just got this letter from Trump’s transition team: On January 16, 2017, CNN broadcast a story by Manu Raju, titled “First on CNN: Trump’s Cabinet pick invested in company, then introduced a bill to help it”, which omitted facts and drew conclusions in an effort to attack President-Elect Donald Trump’s designee for Secretary of Health and Human Services, Dr. Tom Price.
The facts were available to CNN through House Financial Disclosure Filings. Dr. Price’s position on the Comprehensive Joint Replacement demonstration, which date back to fall 2015, is also a matter of public record.
The facts are:
• Dr. Tom Price has a diversified portfolio with Morgan Stanley in a broker-directed account. The portfolio includes both health care and non-health care related stocks. • Dr. Price’s Morgan Stanley financial advisor designed his portfolio and directed all trades in the account. Pursuant to the arrangement with Morgan Stanley, the financial advisor, and not Dr. Price, has the discretion to decide which securities to buy and sell in his account. • Dr. Price’s financial advisor periodically rebalances his portfolio to ensure proper diversification. On March 17, 2016, Morgan Stanley undertook a comprehensive rebalancing of Dr. Price’s portfolio. In the course of that rebalancing, the advisor purchased 26 shares of Zimmer Biomet, worth $2,697.74, on behalf of Dr. Price. • Dr. Price learned of the purchase of Zimmer Biomet on April 4, 2016, when his financial advisor sent him a list of trades to be disclosed on his House Periodic Transaction Report (PTR). • Dr. Price submitted the PTR reflecting the March trades on April 15, 2016. • Dr. Price began work on his legislative effort to delay the comprehensive joint replacement demonstration project in 2015 in order to preserve treatment options for patients. He sent a Dear Colleague letter regarding this effort on September 21, 2015.
The Presidential Transition Team requests that CNN retract this blatantly false story.
JANUARY 18, 2017 PUNCHING BACK TWICE AS HARD: So I just got this letter from Trump’s transition team: On January 16, 2017, CNN broadcast a story by Manu Raju, titled “First on CNN: Trump’s Cabinet pick invested in company, then introduced a bill to help it”, which omitted facts and drew conclusions in an effort to attack President-Elect Donald Trump’s designee for Secretary of Health and Human Services, Dr. Tom Price.
The facts were available to CNN through House Financial Disclosure Filings. Dr. Price’s position on the Comprehensive Joint Replacement demonstration, which date back to fall 2015, is also a matter of public record.
The facts are:
• Dr. Tom Price has a diversified portfolio with Morgan Stanley in a broker-directed account. The portfolio includes both health care and non-health care related stocks. • Dr. Price’s Morgan Stanley financial advisor designed his portfolio and directed all trades in the account. Pursuant to the arrangement with Morgan Stanley, the financial advisor, and not Dr. Price, has the discretion to decide which securities to buy and sell in his account. • Dr. Price’s financial advisor periodically rebalances his portfolio to ensure proper diversification. On March 17, 2016, Morgan Stanley undertook a comprehensive rebalancing of Dr. Price’s portfolio. In the course of that rebalancing, the advisor purchased 26 shares of Zimmer Biomet, worth $2,697.74, on behalf of Dr. Price. • Dr. Price learned of the purchase of Zimmer Biomet on April 4, 2016, when his financial advisor sent him a list of trades to be disclosed on his House Periodic Transaction Report (PTR). • Dr. Price submitted the PTR reflecting the March trades on April 15, 2016. • Dr. Price began work on his legislative effort to delay the comprehensive joint replacement demonstration project in 2015 in order to preserve treatment options for patients. He sent a Dear Colleague letter regarding this effort on September 21, 2015.
The Presidential Transition Team requests that CNN retract this blatantly false story.
No they shouldn't. It's up to him to prove that he wasn't aware and this wasn't some crazy coincidence
So Guilty until proven innocent then, Comrade?
fuckin race beat me to the punch
in this case, when the guy is being appointed to an executive position in that very field, yes. We're not talking about jailtime or him losing his house seat. Isn't that the point of a confirmation hearing? so he can prove and demonstrate that he's qualified for the role?
Comments
One of those companies was innate immuno.
Price admitted in the hearing today that he personally chose to purchase the stock in innate immuno.
Trump's team said that all of his trades were broker directed.
the fact that he received campaign contributions from that company after introducing that law is far worse. but that corruption is everywhere and not exclusive to price by any means
fuckin race beat me to the punch
Imagine if you looked at the bullshit surrounding her with scrutiny line you are this deal, rather than confirmation bias.
We're not talking about jailtime or him losing his house seat.
Isn't that the point of a confirmation hearing? so he can prove and demonstrate that he's qualified for the role?
Get the fucking vote over with and let's get on with it